Format

Send to

Choose Destination
J Neuroimaging. 2016 Mar-Apr;26(2):240-6. doi: 10.1111/jon.12281. Epub 2015 Aug 3.

Comparison of Glioblastomas and Brain Metastases using Dynamic Contrast-Enhanced Perfusion MRI.

Author information

1
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY.
2
 Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY.

Abstract

PURPOSE:

To compare glioblastoma and brain metastases using T1-weighted dynamic contrast-enhanced (DCE)-MRI perfusion technique.

METHODS:

26 patients with glioblastoma and 32 patients with metastatic brain lesions with no treatment who underwent DCE-MRI were, retrospectively, analyzed. DCE perfusion parameters K(trans) and Vp were calculated for the whole tumor. Signal intensity time curves were quantified by calculating the area under the curve (AUC) and the logarithmic slope of the washout phase to explore the heterogeneous tumor characteristics.

RESULTS:

Glioblastoma did not differ from all brain metastases in K(trans) (P = .34) or Vp (P = .47). Glioblastoma and melanoma metastases differed from hypovascular metastases in AUC and log slope of the washout phase of the signal intensity time curve (P < .05); however, glioblastoma and melanoma metastases did not differ from each other (AUC: P = .78, Log slope: P = .77). Glioblastoma and melanoma metastases differed from hypovascular metastases in the ratio of Voxelneg /Voxelpos (P< .03); however, they did not differ from each other. Glioblastoma and melanoma metastases differed from each other in Voxelneg_threshold at higher negative log slope threshold.

CONCLUSION:

DCE-MRI showed that it has a potential to differentiate glioblastomas, melanoma metastases and hypovascular brain tumors. Logarithmic slope of the washout phase and AUC of the signal intensity time curve were shown to be the best discriminator between hypervascular and hypovascular neoplasms.

KEYWORDS:

Glioblastoma; brain; dynamic contrast-enhanced (DCE) MRI; metastasis; neoplasm

PMID:
26235208
PMCID:
PMC4753138
DOI:
10.1111/jon.12281
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center